Biomarker Test Market Research Report - Global Forecast to 2022
ID: MRFR/LS/2428-CRR | April, 2017 | Region: Global | 82 pages | Cooked Research Reports
Global Biomarker Test Market Information, by application (Cancer, Cardiovascular, Infectious Diseases, Central Nervous System, Others) by End User (Pharma & Biotech Companies, Diagnostic tool companies, Healthcare IT/Big data companies, Clinical laboratories) - Forecast to 2022
Market Synopsis of Global Biomarker Test Market:
Market Scenario:
Most healthcare professionals use diagnosis tests to clarify and support their clinical decision making. Progressively over recent years, the analytic procedure has turned out to be stronger by the need to preselect patients in light of medications and licenses. This move has come to through various factors, which incorporate propelling technology (empowering professionals to measure more particular markers of adequacy), an increased comprehension of the disease procedure, and a more prominent energy about the uniqueness of an individual's tumour at the molecular level. These components are reflected in the changing outline of clinical trials. But this move is driven by societal elements as well as, most noticeable among which is the need to limit targeted therapies to those patients destined to benefit. With the appearance of customized/precision prescription, the one-estimate fits-all approach is being consigned to history of life science..
The global market for Biomarker test is expected to reach USD 16,112.8 million by the end of the forecasted period 2016-2022 and is expected to grow at a CAGR of 14.5%.
Study Objectives Global Biomarker Test Market:
- To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the Global Biomarker test Market
- To provide insights about factors affecting the market growth
- To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
- To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
- To provide country level analysis of the market with respect to the current market size, volume, average selling price and future prospective
- To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally
Global Biomarker Test Market, by Application, 2015 (%):
Intended Audience
- Biomarker test device Manufacturer
- Biomarker test device Vendors
- Private Research Laboratories
- Pharmaceutical & Biotechnology Companies
- Market Research and Consulting Service Providers
- Medical Research Laboratories
Key Finding
- The global Biomarker test market and is expected to reach USD 16,112.8 million by 2022.
- On the basis of application, cancer holds the largest market share of global Biomarker test market and is expected to reach USD 5,395.6 million by 2022.
- By end users, Pharma & Biotech companies holds the largest market share of global Biomarker test market is expected to reach USD 5,451.8 million by 2022.
Key Players for Global Biomarker Test Market:
Some of the key players in this market are: F. Hoffmann-La Roche AG, Novartis AG, PFIZER INC., GlaxoSmithKline plc., GE Healthcare, Medtronics, Quest Diagnostics and others.
Segments:
Global Biomarker test Market has been segmented on the basis of application which comprises of Cancer, Cardiovascular, Infectious Diseases, Central Nervous System. On the basis of end users which includes Pharma & Biotech Companies, Diagnostic tool companies, Healthcare IT/Big data companies, Clinical laboratories.
Regional Analysis of Global Biomarker Test Market:
The global market for Biomarker test is growing rapidly. The market for Biomarker test is growing with the CAGR of 14.5% during the forecast period from 2016-2022. North America accounts for largest market share in 2015 and is expected to reach USD 6,640.4 million by 2022.
Asia-Pacific region is the fastest growing market for Biomarker test, which is expected to grow at a CAGR of 15.2% during the forecast period from 2016 to 2022.
The report for Global Biomarker test Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions
